KINS

Analyst Note: Kingstone Companies, Inc. (KINS)

Date: 2026-06-13 Current Price: $16.25

1. Structural Readiness

• Conservative Entry: Not yet triggered (awaiting confirmed breakout above the coil resistance).
• Aggressive/Pre-Breakout Entry: Not applicable for conservative sizing; current price ($16.25) represents the consolidation zone.
• Breakout Level: Not yet fired.
• Current Price: $16.25.
• Extension: — (Price is within the consolidation range, not extended above the breakout level).
• ATR Context: Current ATR is 3.9% (Productive). This sits within the historical "sweet spot" (4–6% is ideal, 3.9% is slightly below but indicates healthy, non-extreme volatility suitable for positioning).

2. Thesis Layer

• Thesis Classification: TACTICAL / SETUP-LED.
• Macro Thesis: There is no named secular thesis attached to this name as of 2026-06-13.
• Judgment Framework: The investment case must be judged strictly on the quality of the technical setup (the forming coil) and the strength of the underlying business fundamentals (growth execution and margin expansion). Do not invent a macro narrative; the conviction rests on the company's ability to execute its stated growth plan and the market's reaction to that execution.

3. Business Overview

Kingstone Companies, Inc. operates through its subsidiary, Kingstone Insurance Company (KICO), a New York domiciled carrier.

• Core Business: KICO writes personal lines and commercial auto insurance primarily through retail and wholesale agents. As of 2025, it was the 11th largest writer of homeowners insurance in New York.
• Product Mix: Personal lines dominate, accounting for 94.7% of gross written premiums in 2025. Specific lines include homeowners, dwelling fire, condo/co-op, renters, and personal umbrella policies. The company also offers specialized commercial coverage for for-hire vehicles (livery, taxi) and canine liability.
• Distribution: Business is generated through relationships with over 700 producers.
• Recent Performance (as of Q1 2026):
• Direct premiums written for the three months ended March 31, 2026, were $69.6 million, a 19.6% increase year-over-year compared to $58.2 million in Q1 2025.
• New business policies grew 19% year-over-year, with average renewal premiums up 10% and retention increasing by approximately 1 percentage point.
• The company is executing a "Withdrawal Plan" to capture market share from competitors pivoting away from admitted personal lines in Downstate New York.
• Expansion Plans (Management Expectations):
• California: Entered the market in Q2 2026 on an excess and surplus lines basis (E3, E17).
• Connecticut: Expected to begin writing admitted homeowners business in Q3 2026 (E4, E19).
• Future: Plans to enter two additional states in 2027 (E13).
• Strategic Shift: The company reduced its quota share from 16% to 5% for its core New York business (E2, E16), signaling confidence in the quality of its retained book and a move toward higher retention of underwriting profits.
• Guidance (Recorded as of May 8, 2026): Management expects direct premiums written growth of 15% to 20%, an underlying combined ratio of 74% to 76%, and diluted EPS of $2.20 to $2.90 for the fiscal year.

4. Archetype and Conviction Stack

• Archetype: Margin Inflector.
• *Fit:* The company is demonstrating a clear path to margin expansion through a combination of aggressive premium growth (15-20% guidance), improved retention, and a strategic reduction in quota share (increasing retained earnings per policy). The "Select" homeowner product line shows claim frequency 33% lower than legacy products, directly supporting the margin inflector thesis (E6).
• Valuation Context:
• Forward consensus EPS (FY1) is $2.60, and FY2 is $3.00 (E27).
• At a current price of $16.25, the stock trades at approximately 6.2x FY1 EPS and 5.4x FY2 EPS.
• Management guidance suggests FY2026 EPS could reach $2.90, implying a forward multiple of roughly 5.6x based on guidance.
• Conviction Stack:
• Thesis Strength: Moderate. The business model is sound, but the lack of a named secular thesis limits the "story" to pure execution.
• Evidence Quality: High. The evidence base is robust, with specific guidance, financial metrics, and expansion timelines provided in Q1 2026 earnings and filings.
• Structural Quality: Positive. The "Forming" coil indicates a healthy consolidation above support. The ATR of 3.9% suggests the stock is not overextended or stagnant.
• Rerating Potential: High. The combination of 20% growth, sub-75% combined ratios, and expansion into high-value markets (CA, CT) provides a clear catalyst for multiple expansion if the "Forming" coil breaks out.
• Setup Readiness: Partial. The setup is "Forming," meaning it is a watch-list candidate with high probability of success but not yet a confirmed entry signal.

5. Invalidations, Strengths, and Gaps

• What Would Invalidate:
• A significant deviation from the 15-20% premium growth guidance or a combined ratio widening beyond 76% (fundamental invalidation).
• Failure to launch in California in Q2 2026 or Connecticut in Q3 2026 as planned.
• What Would Strengthen:
• A confirmed breakout above the coil resistance level (technical confirmation).
• Further evidence of the "Select" product line's superior loss ratios driving overall margin expansion.
• Successful expansion into the new states with premium growth exceeding the 15-20% guidance.
• Gaps in Evidence:
• Detailed CA/CT Financials: While the *plans* to enter are clear, the actual financial contribution from these new markets is not yet realized or quantified in the provided data (as they are just entering or about to enter).
• Long-term Retention Data: While 1-point retention improvement is noted, long-term retention trends beyond the immediate quarter are not detailed.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: 19.6% Q1 premium growth with 19% new business growth; Management guidance for 15-20% growth and 74-76% combined ratio; Strategic reduction of quota share from 16% to 5% indicating high confidence in book quality. Key risks: Execution risk in new state expansions (California/Connecticut); Catastrophe loss ratio volatility (7-10 points guidance); Lack of named secular thesis limiting multiple expansion catalysts. Sizing hint: Position size should reflect the "Forming" status; treat as a partial position awaiting breakout confirmation rather than a full conviction entry. Expected horizon: 3 to 6 months for the setup to resolve (breakout or invalidation).